Comparative Toxicity of Citalopram and the Newer Antidepressants after Overdose

Journal of Toxicology - Clinical Toxicology

Volumn 42, Issue 1, 2004, Pages 67-71

  Kelly, C A ^a   Dhaun, N ^a   Laing, W J ^a   Strachan, F E ^a   Good, A M ^a   Bateman, D N ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Citalopram; Mirtazapine; Nefazadone; Poisoning; Venlafaxine

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGITATION; ARTICLE; CARDIOTOXICITY; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CRITICAL ILLNESS; DRUG OVERDOSE; ELECTROCARDIOGRAM; FEMALE; GLASGOW COMA SCALE; HEART ARRHYTHMIA; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PULSE RATE; QT PROLONGATION; RETROSPECTIVE STUDY; SEIZURE; SEROTONIN SYNDROME; SINUS TACHYCARDIA; TREMOR;

ADMINISTRATION, ORAL; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; MIANSERIN; OVERDOSE; POISONING; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TRIAZOLES;

EID: 1842533368     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120028747     Document Type: Article

References (20)

1. Sclar DA, Robinson LM, Skaer TL, Galin RS. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. Clin Ther 1998; 20:871-874.
2. Barbery JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59(suppl 15):42-48.
3. Sarko J. Antidepressants old and new. A review of their adverse effects and toxicity in overdose. Emerg Med Clin North Am 2000; 18:637-654.
4. Grundemar L, Wohlfart B, Lagerstedt C, Bengtsson F, Eklundh G. Symptoms and signs of severe citalopram overdose. Lancet 1997; 349:1602.
5. Ostrom M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348:339-340.
6. Isbister GK, Dawson AH, Whyte IM. Relative toxicity of citalopram and other selective serotonin reuptake inhibitors in overdose. Clin Toxicol 2002; 40:275.
7. Blythe D, Hackett LP. Cardiovascular and neurological toxicity of venlafaxine. Human Exp Toxicol 1999; 18:309-313.
8. Partridge SJ, MacIver DH, Solanki T. A depressed myocardium. Clin Toxicol 2000; 38:453-455.
9. Fantaskey A, Burkhart KK. A case report of venlafaxine toxicity. Clin Toxicol 1995; 33:359-361.
10. Oliver JJ, Kelly C, Jarvie D, Denieul S, Bateman DN. Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports. Human Exp Toxicol 2002; 21:463-466.
11. Daniels RJ. Serotonin syndrome due to venlafaxine overdose. J Accid Emerg Med 1998; 15:333-337.
12. Velazquez C, Carlson A, Stokes KA, Leikin JB. Relative safety of mirtazapine overdose. Vet Hum Toxicol 2001; 43:342-344.
13. Bremner JD, Wingard P, Walshe TA. Safety of mirtazapine in overdose. J Clin Psychiatry 1998; 59:233-235.
14. Benson BE, Mathiason M, Dahl B, Smith K, Foley MM, Jones Eason LA, Butler AY. Toxicities and outcomes associated with nefazadone poisoning. An analysis of 1,338 exposures. Am J Emerg Med 2000; 18:587-592.
15. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995; 10(suppl 4):37-45.
16. Personne M, Sjoberg G, Persson H. Citalopram overdose-review of cases treated in Swedish hospitals. Clin Toxicol 1997; 35:237-240.
17. Catalano G, Catalano MC, Epstein MA, Tsambiras PE. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24:158-162.
18. Fitzsimmons CR, Metha S. Serotonin syndrome caused by overdose with paroxetine and moclobemide. J Accid Emerg Med 1999; 16:293-295.
19. Kolecki P. Isolated venlafaxine-induced serotonin syndrome. J Emerg Med 1997; 15:491-493.
20. Whyte IM, Dawson AH. Relative toxicity of venlafaxine and serotonin reuptake inhibitors in overdose. Clin Toxicol 2001; 39:255.